ATI-3009(Antidote Therapeutics)

N/A

Report date: 2024/11/21 15:14:16

Base Information

Drug NameATI-3009(Antidote Therapeutics)
Drug Alias NameATI-3009
ClassificationBiologics > Protein drugs > EnzymeBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionEnzymes stimulants
TargetsEnzymes
Therapy Area/IndicationsSmoking Cessation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Scripps Research Institute Inc
Inactive CompaniesN/A
Active IndicationsSmoking Cessation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A